RIGEL PHARMACEUTICALS, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2019
Total Assets: $147.6M
Liabilities Breakdown FY2019
Total Liabilities: $93.8M
Asset Breakdown
Total Assets: $147.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $22.5M | 15.3% |
| Accounts Receivable | $10.1M | 6.9% |
| Inventory | $1.4M | 0.9% |
| Property, Plant & Equipment | $2.2M | 1.5% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $111.4M | 75.5% |
Liabilities Breakdown
Total Liabilities: $93.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.2M | 4.4% |
| Long-Term Debt | $10.0M | 10.7% |
| Other Liabilities | $79.6M | 84.9% |